We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients

    Background

    Metastatic rectal cancer is an incurable malignancy, which is prone to early mortality. We aimed to establish nomograms for predicting the...

    Yanli Li, Ting Tao, Yun Liu in BMC Gastroenterology
    Article Open access 26 February 2024
  2. Predictors for temporary stomas non-closure among non-metastatic rectal cancer patients undergoing curative resection: a retrospective analysis

    Background

    The primary treatment for non-metastatic rectal cancer is curative resection. However, sphincter-preserving surgery may lead to...

    Chia-Chien Hsu, Wen-Sy Tsai, ... Shu-Huan Huang in World Journal of Surgical Oncology
    Article Open access 07 May 2024
  3. Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area

    Background

    Although previous studies have demonstrated that tumor deposits (TDs) are associated with worse prognosis in colon cancer, their clinical...

    Daisuke Yamai, Yoshifumi Shimada, ... Toshifumi Wakai in International Journal of Clinical Oncology
    Article 22 July 2023
  4. Added value of spectral parameters in diagnosing metastatic lymph nodes of pT1-2 rectal cancer

    Purpose

    To investigate the added value of spectral parameters derived from dual-layer spectral detector CT (SDCT) in diagnosing metastatic lymph nodes...

    **kai Liu, Hao Pan, ... Langlang Tang in Abdominal Radiology
    Article 02 March 2023
  5. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis

    Objectives

    This study evaluated pretreatment magnetic resonance imaging (MRI)–detected extramural venous invasion (pmrEMVI) as a predictor of survival...

    Seung Yoon Yang, Hee** Bae, ... Joon Seok Lim in European Radiology
    Article 23 November 2023
  6. An isolated vaginal metastasis from rectal cancer: a case report

    Introduction

    Vaginal metastasis from colorectal cancer is a rare occurrence, typically associated with other metastatic lesions. Isolated metastasis...

    Saida Sakhri, Ines Zemni, ... Tarek Ben Dhiab in Journal of Medical Case Reports
    Article Open access 02 May 2024
  7. Immunotherapy in rectal cancer patients—a propensity score matched analysis of the National Cancer Database

    Background

    Rectal cancer patients with microsatellite instability (MSI-H) are candidates for immunotherapy. However, there is little evidence on its...

    Nir Horesh, Sameh Hany Emile, ... Steven D. Wexner in International Journal of Colorectal Disease
    Article 22 December 2023
  8. An optimised liver-first strategy for synchronous metastatic rectal cancer leads to higher protocol completion and lower surgical morbidity

    Introduction

    The optimal management of rectal cancer with synchronous liver metastases remains debatable. Thus, we propose an optimised liver-first...

    Julien Bonnet, Hélène Meillat, ... Bernard Lelong in World Journal of Surgical Oncology
    Article Open access 03 March 2023
  9. Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy

    Background

    The neoadjuvant rectal score (NAR score) has recently been proposed as a better prognostic model than the conventional TNM classification...

    Kazushige Kawai, Kosuke Ozaki, ... Soichiro Ishihara in International Journal of Clinical Oncology
    Article 09 April 2024
  10. Rectal linitis plastica as the first presentation of metastatic lobular breast cancer: an endoscopic ultrasound diagnosis

    Gastrointestinal tract is an uncommon site of breast cancer metastasis. Rectal linitis plastica (RLP) is a rare presentation of rectal neoplasia,...

    Stefano Mazza, Carmen Laurenza, ... Roberto Grassia in Clinical Journal of Gastroenterology
    Article 13 September 2022
  11. Elderly Rectal Cancer: An Updated Review

    Purpose of Review

    Treatment of rectal cancer patients of advanced age should be modulated by life expectancy and tolerance. Due to the rapid advance...

    Chih-Kai Huang, Chi-Hsiu Shih, Yung-Shuo Kao in Current Oncology Reports
    Article 25 January 2024
  12. Primary adenocarcinoma arising from rectal implantation cyst after low anterior resection for rectal cancer 31 years previously

    Rectal implantation cysts can occur at anastomotic sites after low anterior resection (LAR) for rectal cancer. Herein, we report a case of primary...

    Yoshifumi Shimada, Akio Matsumoto, ... Toshifumi Wakai in Clinical Journal of Gastroenterology
    Article 10 June 2024
  13. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer

    Objectives

    This study aimed to identify whether apparent diffusion coefficient (ADC) values and dynamic contrast-enhanced magnetic resonance imaging...

    Qiaoyu Xu, Yanyan Xu, ... Sheng **e in European Radiology
    Article 15 December 2022
  14. Mechanisms of metastatic colorectal cancer

    Despite extensive research and improvements in understanding colorectal cancer (CRC), its metastatic form continues to pose a substantial challenge,...

    Adrià Cañellas-Socias, Elena Sancho, Eduard Batlle in Nature Reviews Gastroenterology & Hepatology
    Article 28 May 2024
  15. CACA guidelines for holistic integrative management of rectal cancer

    Purpose

    Colorectal cancer is a common malignant tumor worldwide. In China, the ratio of rectal cancer to colon cancer in terms of incidence is close...

    Guiyu Wang, Daiming Fan, ... **shan Wang in Holistic Integrative Oncology
    Article Open access 21 February 2023
  16. Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab

    Herein, we report the successful treatment using atezolizumab plus bevacizumab of a patient with hepatocellular carcinoma (HCC) with a portal vein...

    Yoshitaka Inaba, Shohei Chatani, ... Hidekazu Yamaura in Clinical Journal of Gastroenterology
    Article 11 February 2024
  17. Development and validation of a nomogram to predict overall survival in young non-metastatic rectal cancer patients after curative resection: a population-based analysis

    Purpose

    This study aimed to establish and validate a nomogram for predicting overall survival (OS) in young non-metastatic rectal cancer (RC) patients...

    Zhenya Jia, Huo Wu, ... Guo** Sun in International Journal of Colorectal Disease
    Article Open access 21 October 2022
  18. Prophylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal Cancer Consortium

    Purpose

    Anastomotic leak (AL) is a complication of low anterior resection (LAR) that results in substantial morbidity. There is immense interest in...

    Katherine Hrebinko, Vincent P. Anto, ... Jennifer Holder-Murray in International Journal of Colorectal Disease
    Article Open access 18 March 2024
  19. Surgical management of rectal cancer with synchronous treatment of prostate cancer

    Purpose

    To assess the safety and efficacy of synchronous treatments for rectal (RC) and prostate (PC) cancers.

    Methods

    Single-center retrospective...

    Raphaëlle Brière, André-Guy Martin, ... Sébastien Drolet in Langenbeck's Archives of Surgery
    Article 20 April 2024
  20. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy

    Background

    Immune Checkpoint Inhibitor (ICI) immunotherapy is most effective in immune effector cell infiltrated ‘hot’ tumor lesions, such as occurs...

    Ariel Hirschfeld, Daniel Gurell, Michael Har-Noy in Translational Medicine Communications
    Article Open access 14 May 2024
Did you find what you were looking for? Share feedback.